A Prospective Study to Evaluate the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation (SURE) Using the CVAC® Set
| Registry | NCT06615713, acronym CLEARANCE |
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; na, single group, masking: none, treatment |
| Enrollment | 30 (Actual) |
| Sponsor | Calyxo, Inc. (Industry) |
| Conditions | Renal Stones, Kidney Stone, Urolithiasis |
| Interventions | Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System (Device) |
| Dates | start 2024-09-05, primary completion 2025-01-31, completion 2025-01-31, first posted 2024-09-27, last updated 2026-04-28 |
| Locations | 1 site in India |
Related Papers Related Patents Related Grants Related Experts
All trials for Renal Stones All trials for Kidney Stone All trials of Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System
-Summary
The purpose of the study is to assess safety and efficacy of a novel steerable ureteral catheter system, the CVAC System for the treatment of urinary stones.
Expand all sections · Collapse all
+Arms and interventions
| Arm | Type | Interventions | Description |
|---|
| Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System | Experimental | Device: Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System | The CVAC Aspiration System is a sterile, single use, steerable ureteral catheter system with integrated vision, irrigation and aspiration for the treatment and removal of urinary stones (kidney stones, fragments, and dust). |
- Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System (Device): The CVAC Aspiration System is a sterile, single use, steerable ureteral catheter system with integrated vision, irrigation and aspiration for the treatment and removal of urinary stones (kidney stones, fragments, and dust).
+Outcome measures
Primary outcomes
- Stone Clearance (% Reduction in Stone Volume) [30 Days]: The percent reduction (\[Baseline stone volume- 30-Day stone volume\] / Baseline stone volume) in stone volume following intervention, observed on non-contrast CT (NCCT) (2.0mm slice thickness).
A positive result indicates a decrease in stone volume removed during the procedure; a negative value indicates an increase in stone volume following the procedure.
- Residual Stone Volume (RSV) [30 Days]: A continuous quantitative measure of remaining stone volume following intervention, observed on non-contrast CT (NCCT) (2.0mm slice thickness).
- Stone Free Rate (SFR) - Zero Fragments [30 Days]: Where stone free status is defined as zero residual fragments at 30 days observed on non-contrast CT (NCCT) (2.0mm slice thickness). SFR is calculated by determining the number of kidneys in each treatment arm with a stone free status of zero fragments and dividing that by the total number of kidneys treated in the respective treatment arm.
+Eligibility
Sex: All, ages: 18 Years to any
Inclusion Criteria:
* Candidate for ureteroscopy with laser lithotripsy;
* Be willing and able to return for and respond to all study-related follow up procedures; and,
* Have been informed of the nature of the study and have agreed to the IRB approved informed consent form (ICF).
Exclusion Criteria:
* Significant morbidities;
* Unable to meet the treatment and follow up protocol requirements; and,
* Ureteral or kidney abnormalities.
+Posted results
Participant flow
| Milestone | Steerable Ureteroscopic Renal Evacuation (SURE) With the CVAC System |
|---|
| Started | 30 |
| Completed | 26 |
| Not completed | 4 |
Outcome results
- Stone Clearance (% Reduction in Stone Volume) (Primary), Mean, % stone volume removed: Steerable Ureteroscopic Renal Evacuation (SURE) With the CVAC System 96.2 +/- 6.5
- Residual Stone Volume (RSV) (Primary), Mean, mm^3: Steerable Ureteroscopic Renal Evacuation (SURE) With the CVAC System 14.1 +/- 23.0
- Stone Free Rate (SFR) - Zero Fragments (Primary), Count of units, kidneys: Steerable Ureteroscopic Renal Evacuation (SURE) With the CVAC System 13
Adverse events
Time frame: Index Procedure to Post-op Day-30 (POD30)
| Arm | Deaths | Serious adverse events | Other adverse events |
|---|
| Steerable Ureteroscopic Renal Evacuation (SURE) With the CVAC System | 0/30 (0.0%) | 0/30 (0.0%) | 2/30 (6.7%) |
Other adverse events by term
| Term | Organ system | Steerable Ureteroscopic Renal Evacuation (SURE) With the CVAC System |
|---|
| Urinary Tract Infection (UTI) | Renal and urinary disorders | 2/30 |
+Locations (1)
| Facility | City | Country | Status |
|---|
| Muljibhai Patel Urological Hospital | Nadiād | India | |
+Study documents